Futures are higher this morning after stocks closed relatively flat on Thursday. Investors digesting a report that trials of Gilead Sciences' potential coronavirus treatment, remdesivir led to disappointing results, a sign of how important a coronavirus treatment is to Wall Street and markets around the world. We spoke to Frances Newton Stacy, Director of Strategy at Optimal Capital, for more on the markets.